M'LYNN MCKIBBEN: Open Payments
NPI 1427779198 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,974 in 93 payments from 20 companies in 2025. Trend: 2023 $2,471 · 2024 $2,098 · 2025 $1,974
Food & beverage: $1,974
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $265 |
| Noven Therapeutics, LLC | 9 | $177 |
| ABBVIE INC. | 15 | $167 |
| Alkermes, Inc. | 7 | $160 |
| Vanda Pharmaceuticals Inc. | 6 | $154 |
| Lundbeck LLC | 6 | $151 |
| Corium, LLC | 7 | $146 |
| E.R. Squibb & Sons, L.L.C. | 2 | $143 |
| Neurocrine BioSciences, Inc. | 5 | $120 |
| Supernus Pharmaceuticals, Inc. | 6 | $110 |
Products named: AUSTEDO XR, REXULTI, Xelstrym, VRAYLAR, ARISTADA, Azstarys, COBENFY, FANAPT.
Industry payments across FL — which companies pay providers there.
